AnGes MG Inc.

AnGes MG Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY39.49
Market Cap
JPY73.46 B
Shares Outstanding
106.93 M
Public Float
95.87 M

Profile

Address
Saito Bio-Incubator 1F
Osaka Osaka 567
Japan
Employees -
Website http://www.anges.co.jp
Updated 07/08/2019
AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations.

Financials

View All

Ei Yamada
President & Representative Director
Seiji Hirasaki
Director & Executive Officer